Blastic Plasmacytoid Dendritic Cell NeoplasmDendritic CellsDisease Management
Dr. Andrew A. Lane, MD, PhD
NPI1144372111PAC ID7214195890
- Medicare services, 2024
- 128
- Medicare patients, 2024
- 28
- Publications
- 77
- Clinical trials
- 3
- MIPS score, 2024
- 84
- Practice address
- 75 Francis Street, Boston, MA 02115
- Practice phone
- Call (617) 732-5500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lane's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Andrew A. Lane is a hematologist and oncologist in Boston, Massachusetts
Dr. Lane practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.
Dr. Lane's NPI, 1144372111, was assigned on January 18, 2007. Dr. Lane graduated from Washington University School of Medicine in 2006. Dr. Lane holds Massachusetts license 237761.
NPI and contact details
- NPI
- 1144372111NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7214195890
- NPI enumeration date
- January 18, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (617) 732-5500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 46
- Medical school graduation
- 2006
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Andrew A. Lane practices at Brigham and Women's Hospital in Boston, Massachusetts
Dr. Lane's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.
- Brigham and Women's Hospital75 Francis Street, Boston, MA 02115 · Suffolk CountyPhone(617) 732-5500
Source: Dmand AI Affiliation Data
Dr. Andrew A. Lane is affiliated with 3 sites of care and 1 medical group
Dr. Lane's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Lane is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Binney Medical Group. Dmand AI also links Dr. Lane to 1 more hospital outpatient department, named with a free account.
Dana-Farber Cancer InstituteBinney Medical Group1 hospital outpatient departmentName with a free account
See all 4 affiliations for Dr. LaneSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Andrew A. Lane's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lane practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Brigham and Women's Hospital | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Lane practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Mass General Brigham and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Andrew A. Lane is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Lane's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lane is licensed in Massachusetts.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
Hematologists and oncologists near Dr. Lane
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
429hematologists and oncologists in Massachusetts224hematologists and oncologists in Boston16hematologists and oncologists at Brigham and Women's Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Andrew A. Lane billed Medicare for 128 services in 2024
CMS data shows 128 Medicare services from Dr. Lane across 3 procedure codes in 2024, for 28 Medicare patients. Medicare paid $10,641 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2024128
Medicare patients28
Paid by Medicare$10,641
Procedure codes3
Dr. Lane's Medicare services by type, 2022 to 2024
- 2022
- 2024
- Office and hospital visits
- 2022: 1452024: 12812%
Dr. Lane compared with the Massachusetts median for hematologists and oncologists, 2024
- Dr. Lane
- Massachusetts median
- Medicare services
- 128vs 49574% below
- Medicare patients
- 28vs 20086% below
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Lane's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lane?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lane and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Andrew A. Lane treated 28 Medicare patients in 2024, average age 72
CMS counts 28 Medicare patients who saw Dr. Lane in 2024. The largest group is 65 to 74, with 16 patients. 71% of them have high blood pressure, and 61% have high cholesterol. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Lane's median patient age at 67, with 37% women.
Medicare patients, 202428
Average age72
Average risk score2.04
Dr. Lane's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Lane's Medicare patients by sex, 2024
- Women1554%
- Men1346%
Chronic conditions among Dr. Lane's Medicare patients, 2024
- High blood pressure71%
- High cholesterol61%
- Arthritis57%
- Anxiety54%
- Mood disorders43%
- Diabetes39%
Share of Medicare patients with each condition. A patient can have several.
Dr. Lane's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women37%
- Men58%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Andrew A. Lane scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Lane for performance year 2024, reported as part of a group. Dr. Lane accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Lane's MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Lane by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Andrew A. Lane has 77 publications on record
Dmand AI links 77 papers to Dr. Lane, published from 2010 to 2025. 2022 was the busiest year, with 10. The most frequent topics are Dendritic Cells, Hematologic Neoplasms and Skin Neoplasms. Dr. Lane has published most often in Leuk Lymphoma. Dr. Lane's most frequent co-authors are Naveen Pemmaraju, MD, Marlise Rachael Luskin, MD and Daniel Joseph Deangelo, MD, PhD.
Papers77
Years published2010 to 2025
Dr. Lane's papers by year, 2016 to 2025
Topics Dr. Lane writes about most
- Dendritic Cells
- Hematologic Neoplasms
- Skin Neoplasms
- Leukemia, Myeloid, Acute
- Myeloproliferative Disorders
- Hematopoietic Stem Cell Transplantation
- Interleukin-3 Receptor alpha Subunit
- Recombinant Fusion Proteins
Dr. Lane's most frequent co-authors
- Naveen Pemmaraju, MD10 shared papers
- Marlise Rachael Luskin, MD9 shared papers
- Daniel Joseph Deangelo, MD, PhD6 shared papers
Recent publications by Dr. Lane
Cell CycleCell DifferentiationDendritic Cells
See who Dr. Lane researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lane works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Andrew A. Lane has worked on 3 clinical trials
Dmand AI links Dr. Lane to 3 clinical trials, 2 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Blastic Plasmacytoid Dendritic Cell Neoplasm, Histiocytic Disorders, Malignant and Leukemia, Myeloid, Acute. Stemline Therapeutics, Inc. sponsors the most, 2.
Clinical trials with Dr. Lane by phase
- 1Phase 1: 1 trial
- 2Phase 1/2: 2 trials
- NonePhase 2: no trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Lane's trials
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- Histiocytic Disorders, Malignant
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
Investigators on the most trials with Dr. Lane
- Anthony S. Stein, MD2 shared trials
- Oleg E. Akilov, MD, PhD1 shared trial
- Dale Lee Bixby, MD1 shared trial
Recent clinical trials with Dr. Lane
Phase 1 Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (opens in a new tab)
Active, not recruitingPhase 1
Blastic Plasmacytoid Dendritic Cell NeoplasmHistiocytic Disorders, MalignantVenetoclax
Leukemia, Myeloid, AcuteLeukemia, MyeloidTagraxofusp-erzs
Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia (opens in a new tab)
CompletedPhase 1/2
Blastic Plasmacytoid Dendritic Cell NeoplasmHistiocytic Disorders, MalignantTagraxofusp
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Andrew A. Lane received $135,350 in industry payments from 2019 to 2025
CMS Open Payments shows 86 general payments to Dr. Lane from 4 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 93% of the total. Qiagen, LLC paid the most, $111,750. It also lists 1 research payment totaling $225 in 2024.
General payments to Dr. Lane by program year, 2019 to 2025
General payments to Dr. Lane by kind, 2019 to 2025
$135.3Kin total
- Consulting fees$125,78293%
- Honoraria$6,3005%
- Speaker and faculty fees$2,4002%
- Food and beverage$8681%
Companies that paid Dr. Lane the most, 2019 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Andrew A. Lane graduated from Washington University School of Medicine
Dr. Lane graduated from Washington University School of Medicine in 2006.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Andrew A. Lane's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Andrew A. Lane
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Andrew A. Lane's NPI number?
Dr. Andrew A. Lane's NPI number is 1144372111. It was assigned on January 18, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Andrew A. Lane?
Dr. Andrew A. Lane is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Andrew A. Lane practice?
Dr. Lane practices at 75 Francis Street, Boston, MA 02115. Dr. Lane's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dmand AI also links Dr. Lane to 1 hospital outpatient department.
What is Dr. Andrew A. Lane's office phone number?
The practice phone on file for Dr. Lane is (617) 732-5500.
What is Dr. Andrew A. Lane's medical license number?
Dr. Lane holds Massachusetts license 237761.
Which hospitals is Dr. Andrew A. Lane affiliated with?
Dr. Lane practices at Brigham and Women's Hospital in Boston, Massachusetts. Dr. Lane is also affiliated with Dana-Farber Cancer Institute.
What medical group is Dr. Andrew A. Lane part of?
Dr. Lane is linked to Binney Medical Group.
Does Dr. Andrew A. Lane accept Medicare?
Yes. CMS data shows Dr. Lane billed Medicare for 128 services in 2024, and Dr. Lane accepts Medicare assignment.
What is Dr. Andrew A. Lane's MIPS score?
Dr. Lane's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. Andrew A. Lane see?
CMS counts 28 Medicare patients who saw Dr. Lane in 2024, with an average age of 72.
Show 6 more questionsShow fewer questions
What services does Dr. Andrew A. Lane bill to Medicare?
In 2024, Dr. Lane's most billed Medicare services were hospital inpatient care (99232), hospital inpatient care (99233) and hospital inpatient care (99239).
Where did Dr. Andrew A. Lane go to medical school?
Dr. Lane graduated from Washington University School of Medicine in 2006.
Has Dr. Andrew A. Lane received payments from drug or device companies?
CMS Open Payments shows $135,350 in general payments to Dr. Lane from 4 companies from 2019 to 2025. The largest total came from Qiagen, LLC.
How long has Dr. Andrew A. Lane been practicing?
Dr. Lane graduated from medical school in 2006, 20 years ago.
Does Dr. Andrew A. Lane do research?
Dmand AI links 77 publications to Dr. Lane, published from 2010 to 2025. Dr. Lane has worked on 3 clinical trials.
Who does Dr. Andrew A. Lane publish with?
Dr. Lane's most frequent co-authors are Naveen Pemmaraju, MD (10 shared papers), Marlise Rachael Luskin, MD (9 shared papers) and Daniel Joseph Deangelo, MD, PhD (6 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card